Thomas Kneip - Centrotec Member Board
| CEV Stock | EUR 52.50 0.00 0.00% |
Insider
Thomas Kneip is Member Board of Centrotec SE
| Age | 52 |
| Phone | 49 2961 96 631 111 |
| Web | https://www.centrotec.de |
Centrotec Management Efficiency
The company has return on total asset (ROA) of 0.0419 % which means that it generated a profit of $0.0419 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1139 %, meaning that it generated $0.1139 on every $100 dollars invested by stockholders. Centrotec's management efficiency ratios could be used to measure how well Centrotec manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Bcompt Bcom | Astral Foods Limited | 67 | |
| Yoshihito Kinoshita | Food Life Companies | N/A | |
| You Horie | Food Life Companies | N/A | |
| Tomoko Fukuyama | Food Life Companies | N/A | |
| Colin Smith | Astral Foods Limited | 62 | |
| Hiromitsu Kato | Food Life Companies | N/A | |
| Frans Heerden | Astral Foods Limited | 42 | |
| Christiaan Schutte | Astral Foods Limited | 63 | |
| Agric MBA | Astral Foods Limited | 50 | |
| Linda Lisahapanya | Bumrungrad Hospital Public | 70 | |
| Rangsima Thongdee | Bumrungrad Hospital Public | N/A | |
| Evert Potgieter | Astral Foods Limited | 53 | |
| Takaharu Matsuo | Food Life Companies | N/A | |
| Oraphan Buamuang | Bumrungrad Hospital Public | 49 | |
| Leonie Marupen | Astral Foods Limited | 51 | |
| Michael Schmitz | Astral Foods Limited | 62 | |
| David FACHE | Bumrungrad Hospital Public | N/A | |
| Daniel Kastner | Bumrungrad Hospital Public | N/A | |
| Louis Vermaas | Astral Foods Limited | 51 | |
| Artirat Charukitpipat | Bumrungrad Hospital Public | 55 | |
| Tanee Maneenut | Bumrungrad Hospital Public | N/A | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0419 |
Centrotec SE Management Team
Elected by the shareholders, the Centrotec's board of directors comprises two types of representatives: Centrotec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Centrotec. The board's role is to monitor Centrotec's management team and ensure that shareholders' interests are well served. Centrotec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Centrotec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Kneip, Member Board | ||
| Bernhard Pawlik, Member Board | ||
| Gnther Whr, CFO Board |
Centrotec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Centrotec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 590.92 M | |||
| Shares Outstanding | 13.17 M | |||
| Shares Owned By Institutions | 2.20 % | |||
| Price To Book | 3.00 X | |||
| Price To Sales | 1.02 X | |||
| Revenue | 650.98 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Centrotec Stock
Centrotec financial ratios help investors to determine whether Centrotec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Centrotec with respect to the benefits of owning Centrotec security.